Study of 118 patients with malignant peritoneal mesothelioma revealed cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) led to longer overall and progression-free survival. The platinum-pemetrexed combination was effective for metastatic patients and those medically inoperable. Non-surgical patients had poorer prognoses. CRS-HIPEC emerged as a safe and effective treatment, offering better survival outcomes and low morbidity rates.
Journal Article by Yaşar S, Yılmaz F (…) Yalçın Ş et 8 al. in Ann Surg Oncol
© 2024. The Author(s).